125 related articles for article (PubMed ID: 30095463)
1. Detection of mRNA of Telomerase Protein in Benign Naevi and Melanomas Using RNAscope.
Baltzarsen PB; Georgsen JB; Nielsen PS; Steiniche T; Stougaard M
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):36-41. PubMed ID: 30095463
[TBL] [Abstract][Full Text] [Related]
2. In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
Vagner J; Steiniche T; Stougaard M
Histopathology; 2015 Apr; 66(5):747-51. PubMed ID: 25601620
[TBL] [Abstract][Full Text] [Related]
3. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
[TBL] [Abstract][Full Text] [Related]
4. Quantitative in situ evaluation of telomeres in fluorescence in situ hybridization-processed sections of cutaneous melanocytic lesions and correlation with telomerase activity.
Miracco C; Margherita De Santi M; Schürfeld K; Santopietro R; Lalinga AV; Fimiani M; Biagioli M; Brogi M; De Felice C; Luzi P; Andreassi L
Br J Dermatol; 2002 Mar; 146(3):399-408. PubMed ID: 11952539
[TBL] [Abstract][Full Text] [Related]
5. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions.
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276
[TBL] [Abstract][Full Text] [Related]
6. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.
Wang HY; Kim G; Cho H; Kim S; Lee D; Park S; Park KH; Lee H
Exp Mol Pathol; 2015 Jun; 98(3):510-6. PubMed ID: 25835783
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
9. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
10. Different effects of interferon-alpha on melanoma cell lines: a study on telomerase reverse transcriptase, telomerase activity and apoptosis.
Maellaro E; Pacenti L; Del Bello B; Valentini MA; Mangiavacchi P; De Felice C; Rubegni P; Luzi P; Miracco C
Br J Dermatol; 2003 Jun; 148(6):1115-24. PubMed ID: 12828737
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of human telomerase catalytic subunit mRNA by in situ hybridization in pheochromocytomas.
Luo Z; Li J; Qin Y; Ma Y; Liang X; Xian J; Lu D; Wei M; Yang JY; Yang MQ; He Z
Endocr Pathol; 2006; 17(4):387-98. PubMed ID: 17525487
[TBL] [Abstract][Full Text] [Related]
12. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
15. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
[TBL] [Abstract][Full Text] [Related]
16. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
18. Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma.
Uchida N; Tsutsui K; Ezaki T; Fukuma H; Kobara H; Kamata H; Aritomo Y; Masaki T; Watanabe S; Kobayashi S; Nakatsu T; Nakano H; Kuriyama S
Am J Gastroenterol; 2003 Nov; 98(11):2415-9. PubMed ID: 14638342
[TBL] [Abstract][Full Text] [Related]
19. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
20. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
